Unibest
← Back to patent-cliff list

CAS 880160-69-0

methyl 4-(8-fluoro-6-oxo-3,4,5,6-tetrahydro-1H-azepino[5,4,3-cd]indol-2-yl)benzyl(methyl)carbamate

Codes: RUCA-014

Application context (from source-drug indications)

Prostate cancerRucaparib CamsylatePeritoneal cancerRucaparib CamsylateEpithelial ovarian cancerRucaparib CamsylateFallopian tube cancerRucaparib CamsylateOvarian cancerRucaparib CamsylateCastration-resistant prostate cancerRucaparib Camsylate

Source drugs (routes using this intermediate)

DrugTierExpiry
Rucaparib CamsylateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.